Findings showed treatment with tavapadon led to a statistically significant improvement in motor function compared with placebo. Topline results were announced from a phase 3 trial evaluating ...

Treatment with dupilumab reduced the annualized rate of moderate or severe COPD exacerbations by 30% in the BOREAS trial and 34% in the NOTUS trial compared with placebo. The Food and Drug ...

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...

Researchers conducted a retrospective cohort study to compare the effects of SGLT-2 inhibitors and DPP-4 inhibitors on Parkinson disease risk among adults with T2D.

Investigators conducted a systematic review and meta-analysis to elucidate the efficacy and safety of cTBS for the treatment of auditory hallucinations in schizophrenia.

“Children are the overlooked tragic victims of the United States’ opioid epidemic, and fentanyl is now the greatest danger,” Quidgley-Martin said in a statement. “We need our first responders to ...

Development of paramagnetic rim lesions tied to more rapid disability progression. HealthDay News — Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis ...